T-cell cytokines: What we have learned from human studies

Paediatric Respiratory Reviews

Volumn 5, Issue SUPPL. A, 2004, Pages

  Robinson, Douglas S ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR3 ANTIBODY; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 9; MESSENGER RNA; MONOCLONAL ANTIBODY; OKT 4; UNCLASSIFIED DRUG; ALLERGEN;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ARTICLE; ASTHMA; ATOPY; B LYMPHOCYTE; BASOPHIL; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENDOTHELIUM CELL; EOSINOPHIL; EPITHELIUM CELL; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; MAST CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; BRONCHOSCOPY; CELL TYPE; CHILD; CHILDHOOD DISEASE; DISEASE SEVERITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG BIOPSY; LUNG LAVAGE; MOLECULAR MECHANICS; PHENOTYPE; REVIEW;

EID: 1342265676     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(04)90011-5     Document Type: Review

References (81)

1. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL. Two types of murine helper T cell clone. I Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
2. Parish CR, Liew FY. Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med 1972; 135: 298-311.
3. Fong TA, Mosmann TR. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 1989; 143: 2887-2893.
4. Del Prete GF, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, de Vries J, Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140: 4193-4198.
5. Sanderson CJ. Interleukin 5, eosinophils and disease. Blood 1992; 79: 3101-3109.
6. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169: 59-72.
7. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988; 168: 1675-1684.
8. Guler ML, Gorham J, Hsieh CS, Mackey AJ, Steen RG, Dietrich WF, Murphy KM. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 1996; 271: 984-987.
9. Parronchi P, Macchia D, Piccinni MP, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991; 88: 4538-4542.
10. Wierenga EA, Snoek M, de Groot C, Chretien I, de Bos J, Jansen HM, Kapsenberg ML. Evidence compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990; 144: 4651-4656.
11. Plaut M, Pierce JH, Watson CJ, Haney-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphkines in response to cross-linkage of FceRI or calcium ionophore. Nature 1989; 329: 64-67.
12. Moqbel R, Ying S, Barkans J, Newman TM, Kimmitt P, Wakelin M, Taborda-Barata L, Meng Q, Corrigan CJ, Durham SR, Kay AB. Identification of mRNA for interleukin-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995; 155: 4939-4947.
13. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993; 177: 605-610.
14. Gauchat J-F, Henchoz S, Mazzei G, Aubry J-P, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Bonnefoy J-Y. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340-343.
15. Geha RS. Regulation of IgE synthesis in humans. J Allergy Clin Immunol 1992; 90: 143-150.
16. Sutton BJ, Gould HJ. The human IgE network. Nature 1993; 366: 421-428.
17. Pene J, Rousset F, Briere F, Chretien I, Wideman J, Bonnefoy JY, de Vries JE. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol 1988; 18: 929-935.
18. Vercelli D, Jabara HH, Arai K, Yokota T, Geha RS. Endogenous IL-6 plays an oligatory role in IL-4-induced human IgE synthesis. Eur J Immunol 1989; 19: 1419-1422.
19. Dugas B, Renauld JC, Pene J, Bonnefoy JY, Peti-Frere C, Braquet P, Bousquet J, Van-Snick J, Mencia Huerta JM. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993; 23: 1687-1692.
20. Gauchat J-F, Henchoz S, Mazzei G, Aubry J-P, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Bonnefoy J-Y. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340-343.
21. Denburg JA, Silver JE, Abrams JS. Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors. Blood 1991; 77: 1462-1468.
22. Huston MM, Moore JP, Mettes HJ, Tavana G, Huston DP. Human B cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis. J Immunol 1996; 156: 1392-1401.
23. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G. A human high affinity interleukin 5 receptor (IL-5R) is composed of an IL-5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 1991; 66: 1175-1184.
24. Kitamura T, Sato N, Arai K, Miyajima A. Expression cloning of the human interleukin 3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991; 66: 1165-1174.
25. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin 5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 1989; 73: 1504-1512.
26. Tavernier J, Van der Heyden J, Verhee A, Brusselle G, Van Ostade X, Vandekerckhove J, North J, Rankin SM, Kay AB, Robinson DS. Interleukin 5 regulates the isoform expression of its own receptor α-subunit. Blood 2000; 95: 1600-1607.
27. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Brakans J, Bentley AM, Corrigan CJ, Durham SR, Kay AB. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
28. Robinson DS, Ying S, Bentley AM, Meng Q, North J, Durham SR, Kay AB, Hamid Q. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92: 397-403.
29. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow J-C Jr. Allergic and non-allergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146: 109-115.
30. Del Prete GF, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23: 1445-1449.
31. + T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol 1995; 25: 2727-2731.
32. Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, Larche M, Robinson DS, Durham SR, Kay AB. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997; 158: 3539-3544.
33. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 1998; 161: 1501-1509.
34. Haselden BM, Kay AB, Larche M. IgE-independent MHC-restricted T cell peptide epitope-induced late asthmatics reactions. J Exp Med 1999; 189: 1885-1894.
35. Haselden BM, Larche M, Meng Q, Shirley K, Dworski R, Kaplan AP, Bates C, Robinson DS, Ying S, Kay AB. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol 2001; 108: 394-401.
36. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-2261.
37. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2263.
38. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, Menz G, Kay AB, Corrigan CJ. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997; 99: 657-665.
39. Wang J, Palmer K, Lotval J, Milan S, Feng X, Matthaei KI, Gauldie J, Inman MD, Jordana M, Xing Z. Circulating, but not local lung IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998; 102: 1132-1141.
40. Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia and bronchial hyperresponsiveness. J Exp Med 1998; 188: 1307-1320.
41. Tang W, Geba GP, Zheng T, Ray P, Homer RJ, Kuhn C, Flavell RA, Elias JA. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest 1996; 98: 2845-2853.
42. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin 13 causes inflammation, mucus hypersecretion subepithelial fibrosis, physiologic abnormalities and eotaxin production. J Clin Invest 1999; 103: 779-788.
43. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, Nicolaides NC, Holroyd KJ, Tsicopoulos A, Lafitte JJ, Wallaert B, Hamid QA. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 2000; 105: 108-115.
44. Minshall E, Chakir J, Laviolette M, Molet S, Zhu Z, Olivenstein R, Elias JA, Hamid Q. IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol 2000; 105: 232-238.
45. Wills-Karp M, Ewart SL. The genetics of allergen-induced airway hyperresponsiveness; in mice. Am J Respir Crit Care Med 1997; 156: S89-S96.
46. Grasso L, Huang M, Sullivan CD, Messier CJ, Kiser MB, Dragwa CR, Holroyd KJ, Renauld J-C, Levitt RC, Nicolaides NC. Molecular analysis of human interleukin-9 receptor transcripts in peripheral blood mononuclear cells. J Biol Chem 1998; 24016-24024.
47. Soussi Gounni A, Gregory B, Nutku E, Aris F, Latifa K, Minshall E, North J, Tavernier J, Levit R, Nicolaides N, Robinson DS, Hamid Q. Interleukin-9 enhances IL-5 receptor expression, differentiation and survival of human eosinophils. Blood 2000; 96: 2163-2171.
48. Ying S, Meng Q, Kay AB, Robinson DS. Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy 2002; 32: 866-871.
49. Gemou-Engesaeth V, Bush A, Kay AB, Hamid Q, Corrigan CJ. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression. Pediatrics 1997; 99: 695-703.
50. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 697-704.
51. Ennis M, Turner G, Schock BC, Stevenson EC, Brown V, Fitch PS, Heaney LG, Taylor R, Shields MD. Inflammatory mediators in bronchoalveolar lavage samples from children with and without asthma. Clin Exp Allergy 1999; 29: 362-366.
52. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001; 164: 1376-1381.
53. Bentley AM, Menz G, Storz Chr, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB. Identification of T-lymphocytes, macrophages and activated eosinophils in the bronchial mucosa in intrinsic asthma: Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992; 146: 500-506.
54. Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, Larche M, Robinson DS, Durham SR, Kay AB. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997; 158: 3539-3544.
55. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G, Barkans J, Ying S, Kay AB. High affinity IgE receptor (FcεRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 1996; 153: 1931-1937.
56. Valenta R, Natter S, Seiberler S, Wichlas S, Maurer D, Hess M, Pavelka M, Grote M, Ferreira F, Szepfalusi Z, Valent P, Stingl G. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 1998; 111: 1178-1183.
57. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988; 141: 4158-4164.
58. Robinson DS, Hamid Q, Bentley AM, Ying S, Kay AB, Durham SR. CD4+ T cell activation, eosinophil recruitment and interleukin 4 (IL-4), IL-5 and GM-CSF messenger RNA expression in bronchoalveolar lavage after allergen inhalation challenge of atopic asthmatics. J Allergy Clin Immunol 1993; 92: 313-324.
59. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775-778.
60. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte macrophage colony-stimulating factor in the nasal mucosa after allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-2394.
61. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine messenger RNA expression or IL-5 and GM-CSF in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Repir Cell Mol Biol 1993; 8: 35-42.
62. Robinson DS, Hamid Q, Ying S, Bentley AM, Assoufi B, North J, Meng Q, Durham SR, Kay AB. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148: 401-406.
63. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon y gene expression in steroid-resistant asthma. J Exp Med 1995; 181: 33-40.
64. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin A in corticosteroid-dependent chronic severe asthma. Lancet 1992; 339: 324-328.
65. Lock SH, Kay AB, Barnes NC. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med 1996; 153: 509-514.
66. Sihra BS, Durham SR, Walker S, Kon OM, Barnes NC, Kay AB. Inhibition of the allergen-induced late asthmatic response by cyclosporin A. Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax 1997; 52: 447-452.
67. Kon OM, Sihra BS, Compton CH, Leonard TB, Kay AB, Barnes NC. Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet 1998; 352: 1109-1113.
68. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154: 4187-4194.
69. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178: 2123-2130.
70. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996; 97: 1356-1365.
71. Borish LC, Nelson HS, Lanz MJ, Claussen L, Whitmore JB, Agosti JM, Garrison L. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160: 1816-1823.
72. Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB, Agosti JM. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001; 107: 963-970.
73. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-2148.
74. Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Bock JA, Boyce MJ, Hansel TT, Holgate ST, Barnes PJ. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2149-2153.
75. O'Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol 2001; 108: 503-508.
76. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167: 199-204.
77. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarised T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-883.
78. Zingoni A, Soto H, Hedrick JA, Stoppaccio A, Storlazzi CT, Sinigaglia F, D'Amrosio D, O'Garra A, Robinson DS, Rocchi M, Santoni A, Zlotnick A, Napolitano M. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998; 161: 547-551.
79. Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C, Buonsanti C, Miotto D, Mapp C, Villa A, Arrigoni G, Fabbri LM, Sinigaglia F. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001; 107: 1357-1364.
80. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+)regulatory T cells. J Exp Med 2001; 194: 847-853.
81. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 1997; 385: 81-83.